TCT-188 Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries at 36-Month Follow-Up: BIOSOLVE-II and BIOSOLVE-III | Publicación